News | January 14, 2015

Opsens Announces First use of FFR Products in Europe

OptoWire and OptoMonitor guide therapy in patients with coronary heart disease

FFR catheters, Cath lab, OptoWire, OptoMonitor

Image courtesy of Opsens

January 14, 2015 — Opsens Inc. announced the first use of its Fractional Flow Reserve (FFR) products in Europe by the founders of FFR, namely Bernard De Bruyne, M.D. at the Cardiovascular Center Aalst, Belgium and by professor Nico Pijls, at the Catharina Hospital, Eindhoven the Netherlands. The OptoWire and OptoMonitor are Opsens’ products for FFR measurements to optimize the diagnosis and guide the therapy in patients with coronary heart disease.

"The arrival of an optical FFR guidewire such as the OptoWire on the market is positive for interventional cardiologists who need to obtain reliable FFR measurements. It allowed me to appreciate its zero drift performance during all cases performed while also acknowledging the constant connection reliability as well as its support during percutaneous coronary intervention", said Bernard De Bruyne, M.D., from the Cardiovascular Center Aalst.

The OptoWire provides intra-coronary blood pressure measurements with optical pressure guidewire technologies. It is immune to adverse effects related to blood contact, and allows easy connectivity that leads to reliable FFR measurements in extended conditions of usage. The product is designed to provide cardiologists with a guidewire delivering optimized performances to navigate coronary arteries and reach blockages. Based on industry sources, the FFR market represented more than $250 million in U.S. sales in 2013 and is expected to reach $1 billion in the medium-term.  

For more information: www.opsens.com

 

Related Content

Shockwave Initiates U.S. Pivotal Study for Coronary Intravascular Lithotripsy
News | Cath Lab | January 16, 2019
Shockwave Medical Inc. has initiated its U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE...
National Academy of Engineering, Ohio University Award 2019 Russ Prize
News | Cath Lab | January 03, 2019
Ohio University and the National Academy of Engineering announced the 2019 Fritz J. and Dolores H. Russ Prize will be...
Videos | Cath Lab | January 03, 2019
This is walk through inside one of the cardiac hybrid cath labs at the...
Videos | Cath Lab | January 03, 2019
This is the newest cardiac cath lab at the ...
Study Finds Effective Treatment for Coronary Slow Flow
News | Cath Lab | December 27, 2018
Patients who arrive at the hospital with heart-attack-like symptoms have had little recourse for their chest pain if...
Shockwave Announces Collaboration With Abiomed on Physician Training
News | Cath Lab | December 14, 2018
Shockwave Medical announced a new investment and collaboration agreement with Abiomed Inc. As outlined by the agreement...
Sponsored Content | Videos | Cath Lab | October 24, 2018
Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic suppo
Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Overlay Init